CClinicalTrials.gg
CompletedNCT00505362Updated Nov 6, 2017Results posted

Pain Study of Rectus Muscle Closure at Cesarean Delivery

An interventional study of Rectus closure in Pain, sponsored by Stanford University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-06.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Suture reapproximation of the rectus muscles at primary cesarean delivery is a common practice about which there are no data. Some Obstetricians believe that suture reapproximation of the rectus muscles increases post-operative pain, and it may decrease adhesions, yet there are no published data to support or refute these claims. The purpose of this study is to assess the effect of rectus muscle reapproximation at cesarean delivery and post-operative pain. We also plan to assess the impact of rectus muscle closure on adhesions as seen at repeat cesarean delivery.

Read the detailed description

There are more than 1 million cesarean deliveries performed annually in the United States, at a rate of 30.2% of all deliveries. Data are limited regarding optimal surgical closure techniques to minimize adhesions at cesarean. Adhesions are implicated in pelvic pain, infertility, difficult repeat surgery, and bowel obstruction. Practice techniques regarding rectus muscle reapproximation vary widely, and there are no data regarding the impact of this step on pain, and some data suggesting a reduction in significant adhesions. Given the frequency of cesarean deliveries, small changes in surgical technique may yield significant benefits.

We hope to learn 1) whether suture reapproximation of the rectus muscles increases pain, and 2) the degree to which suture reapproximation of the rectus muscles alters adhesions when studied in a prospective, randomized trial.

All patients undergoing primary cesarean delivery at Lucile Packard Childrens Hospital (LPCH) will be offered the study. Once consented, patients will be randomized to one of two standardized closure techniques at cesarean: two-layer uterine closure, peritoneal closure, fascial and skin closure, and either reapproximation of the rectus muscles with three-interrupted sutures, or non-closure. Intra-operative and post-operative pain management will be standardized. Subjects will undergo pain assessments while in-house on post-operative days 1 and 3, and at the standard post-partum clinic visit after 6 weeks. These assessments will require less than 5 minutes of the patient's time. Patients will be shown a pain chart, and will be asked to rate their pain on a scale of 0 to 10 at rest. They will then stand up and rate their pain again. Pain medication usage will also be assessed.

The surgeons will know the groups to which the patients are randomized. The patients and those collecting data on pain scores will not.

Primary Endpoint: combined opioid use and movement pain score (Silverman Integrated Assessment-SIA) 72 post-operative hours.

Secondary Endpoint: surgical complications, maternal satisfaction with analgesia.

02

Conditions studied

  • Pain
03

In context

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

37 weeks gestation Primary cesarean American Society of Anesthesiologists (ASA) class 1 or class 2

Exclusion criteria

Exclusion Criteria:

Chronic analgesia use Vertical skin incision at cesarean Opioid or Non-steroidal anti-inflammatory drugs (NSAID) allergy BMI >40 Labor

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
63 participants (actual)

Study arms

  • Active comparator
    Rectus muscle closure

    Two-layer uterine closure, peritoneal closure, fascial and skin closure and reapproximation of the rectus muscles with three-interrupted sutures.

    Procedure: Rectus closure

  • No intervention
    Rectus muscle non-closure

    Two-layer uterine closure, peritoneal closure, fascial and skin closure, and rectus muscles non-closure.

Interventions

  • ProcedureRectus closure

    Reapproximation of the rectus muscles with three-interrupted sutures

06

What researchers measure

Primary outcomes

  1. Post-operative Pain

    Post-operative pain was assessed using Silverman Integrated Assessment (SIA) pain score which combines the opioid use and movement pain score over the 72-hour study period. The SIA pain and opioid score is calculated by first rank ordering each patient's total opioid use (morphine milligram equivalents) and area under the curve (AUC) movement pain score over the 72 hour study period, then calculating a mean for both opioid use and movement pain scores, expressing both opioid use and movement pain score as percent differences from the mean, and lastly adding the percent differences from the mean for the two variables. The SIA composite score value for each subject ranges from approximately 200% to approximately -200%, with the highest positive score indicating the least comfortable or the most pain despite the greatest use of analgesics, and the lowest score indicating the most comfortable or least pain despite the least use of analgesics.

    Time frame: 72-hour study period

Secondary outcomes

  1. Operative Times

    Operative time of the cesarean delivery in minutes.

    Time frame: From start to the end of the cesarean delivery, assessed up to two hours.

07

Results

Posted Mar 27, 2017

Participant flow

Participant flow — Overall Study
MilestoneRectus Muscle ClosureRectus Muscle Non-closure
Started3528
Completed3528
Not completed00

Outcome measures

PrimaryPost-operative Pain

Post-operative pain was assessed using Silverman Integrated Assessment (SIA) pain score which combines the opioid use and movement pain score over the 72-hour study period. The SIA pain and opioid score is calculated by first rank ordering each patient's total opioid use (morphine milligram equivalents) and area under the curve (AUC) movement pain score over the 72 hour study period, then calculating a mean for both opioid use and movement pain scores, expressing both opioid use and movement pain score as percent differences from the mean, and lastly adding the percent differences from the mean for the two variables. The SIA composite score value for each subject ranges from approximately 200% to approximately -200%, with the highest positive score indicating the least comfortable or the most pain despite the greatest use of analgesics, and the lowest score indicating the most comfortable or least pain despite the least use of analgesics.

Time frame:
72-hour study period
Reported as:
Mean · Scores on a scale
Post-operative Pain
Scores on a scaleRectus Muscle ClosureRectus Muscle Non-closure
Post-operative Pain15 ± 100-31 ± 78
Statistical analysis
  • Rectus Muscle Closure vs Rectus Muscle Non-closure · t-test, 2 sided · p = 0.04
SecondaryOperative Times

Operative time of the cesarean delivery in minutes.

Time frame:
From start to the end of the cesarean delivery, assessed up to two hours.
Reported as:
Mean · minutes
Operative Times
minutesRectus Muscle ClosureRectus Muscle Non-closure
Operative Times63 ± 1565 ± 15
Statistical analysis
  • Rectus Muscle Closure vs Rectus Muscle Non-closure · t-test, 2 sided · p = 0.61

Adverse events

Collected over 6 weeks after the delivery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Rectus Muscle Closure—0/35 (0%)0/35 (0%)
Rectus Muscle Non-closure—0/28 (0%)0/28 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Rectus Muscle ClosureRectus Muscle Non-closureTotal
Mean31 ± 733 ± 732 ± 7
Sex: Female, Male
Sex: Female, Male(Participants)Rectus Muscle ClosureRectus Muscle Non-closureTotal
Female352863
Male000
Region of Enrollment
Region of Enrollment(Participants)Rectus Muscle ClosureRectus Muscle Non-closureTotal
United States352863
Gestational age at delivery
Gestational age at delivery(weeks)Rectus Muscle ClosureRectus Muscle Non-closureTotal
Median39 (37 to 39)38 (37 to 39)39 (37 to 39)
08

Study locations

1 site
  • Stanford University School of Medicine
    Stanford, California 94305, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00505362
Lead sponsor
Stanford University
Responsible party
Deirdre Judith Lyell (Associate Professor of Obstetrics and Gynecology, Stanford University) — Principal investigator
First posted
Jul 23, 2007
Start date
Jun 2006
Primary completion
Aug 2014
Completion
Oct 2017
Results posted
Mar 27, 2017
Last update
Nov 6, 2017

Study contacts

Deirdre Judith Lyell
principal investigator · Stanford University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion